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Abstracts / International Journal of Surgery 23 (2015) S15eS134S30Aim: To demonstrate the role of human ﬁbrin sealant glue for mastectomy
ﬂap adherence.
Methods: We audited the use of ARTISS ﬁbrin sealant glue versus surgical
drain placement for six months at a District General Hospital, looking at
two primary endpoints; discharge within 23 hours and post-operative
complications. All mastectomy patients were included and complications
were identiﬁed up to 60 days. Data was collected prospectively from
physical and electronic records.
Results: Complete data was collected for 18/19 patients who underwent
mastectomy in the study period. The rate of discharge within 23 hours
using ﬁbrin sealant glue was 6/7 patients compared with 5/8 with surgical
drains. For the four patients who had neither drain nor glue, two were
discharged within 23 hours. The rate of seroma with ﬁbrin glue was 1/7
versus 4/8 with a drain. Using neither drain nor glue 2/4 patients devel-
oped seromas and one was re-admitted.
Conclusion: The use of ﬁbrin sealant glue resulted in reduced complica-
tions and earlier discharge compared with surgical drains for mastectomy
patients in this small sample. Larger scale studies are required to
demonstrate statistical signiﬁcance, but ﬁbrin sealant glue may negate the
use of drains, expedite discharges and reduce costs from community
nursing, prolonged admissions, drain complications and delays starting
adjuvant treatment.
0700: THE ROLE OF GUIDELINE REINFORCEMENT IN IMPROVING
QUALITY OF REFERRALS TO A SPECIALIST BREAST CLINIC
S. Davis*, A. Lannigan, J. Murray. Wishaw General Hospital, UK
Aim: To assess the effect of redistributing Scottish Cancer Referral
Guidelines to primary care in improving the quality of referrals to a
specialist breast clinic in a Scottish DGH.
Methods: A previous audit showed 36% referrals from general practice
were either inappropriate or of incorrect level of urgency. The Scottish
Cancer Referral Guidelines were re-distributed to primary care physicians
and referrals were re-audited over a 2 week period.
Results: 231 referrals were made in the study period. 33% were referred as
routine. Of these, 65% were correct and 35% incorrect. Incorrect routine
referrals should have been urgent according to guidelines (54%); the
remainder should have been managed in primary care (46%). This was a
17% improvement over the previous audit. 67% patients were referred as
urgent. Of these, 73% were correct while 27% were incorrect. 86% incorrect
referrals should have been routinewhile 14% should have beenmanaged in
primary care. This was a 6% improvement over the previous audit.
Conclusion: Redistribution of the guidelines did improve the quality of
referrals. Other methods of reinforcement are needed to further improve
standards of referral from primary care and to give general practitioners
the conﬁdence to manage conditions not needing specialist care.
0728: A REVIEW OF THE MANAGEMENT OF AXILLARY
MICROMETASTASES IN BREAST CANCER
M. Green*, H. Ingle. Good Hope Hospital, UK
Aim: Our local protocol suggests undertaking axillary node clearance
(ANC) if a micrometastasis is found at sentinel lymph node biopsy (SLNB).
With recent reports suggesting this may not be necessary, we reviewed
our data between January 2012 and August 2014 (30 months)
Methods: A case note review was performed on all patients undergoing
axillary surgery for breast cancer over a three year period. The form
of axillary surgery, as well as the number of nodes retrieved was
noted. We also noted whether there were micrometastases or
macrometastases.
Results: 163 of a total of 358 patients (45.5%) underwent axillary node
clearance (ANC). Of those, 87 (53.4%) were primary, and 76 (46.6%)
following SLNB. From the 76 secondary ANCs, 21 (27.6%) only had micro-
metastases on SLNB. All underwent ANC. Out of the 21 ANCs for micro-
metastasis, only 2 patients (9.5%) had further nodal involvement. One with
a further solitary micrometastasis, another had 2 involved nodes- one
micrometastasis, one macrometastasis.
Conclusion: ANC with solitary micrometastases has been called into
question, especially with improving adjuvant therapies. This data supportsthat view and suggests that in almost 28% (21/76) of cases we may be
unnecessarily increasing potential morbidity and cost by advocating ANC.
0741: USE OF THE LATISSIMUS DORSI FLAP IN BREAST
RECONSTRUCTION: THE PATIENT PERSPECTIVE
E. Snashall, P. Wadsworth*, C. Harding-MacKean, E. Redmond. Countess of
Chester Hospital, UK
Aim: The latissimus dorsi (LD) ﬂap is one of many available methods of
breast reconstruction following mastectomy. All methods carry key
strengths and potential pitfalls; no method can exactly replace the lost
breast. This study aims to assess patient perspective of outcome following
breast reconstruction with LD ﬂap.
Methods: 29 patients completed satisfaction surveys assessing aesthetic,
pain and functional outcomes.
Results: Mean overall satisfaction score was 8.9/10 and 28/29 (96.6%)
would recommend the procedure. The most important factors in
aesthetic outcome were symmetry (10/29, 34.5%) and shape (10/29,
34.5%). Eight (27.6%) reported mild/moderate restrictions in activities and
six (20.6%) reported moderate pain; none reported signiﬁcant limitation
or pain.
Conclusion: LD ﬂap reconstruction was associated with high overall pa-
tient satisfaction comparable to DIEP which is considered as the gold
standard, and little functional or aesthetic compromise. The most impor-
tant factor for patients was symmetry. Patient expectations and priorities
should be a key point to address in a reconstruction consultation. The
ultimate aim should be for an outcome which has addressed the factors
most important to that individual patient.
0763: EFFICACY OF TRIPLE ASSESSMENT IN COMPARISON WITH
SURGICAL BIOPSY IN BREAST CANCER
M.I. Aslam a, M.O. Karim b,*, A. Khan c, P.K. Arora c. a South Warwick NHS
Foundation Trust, UK; b John Radcliffe Oxford University Hospital, UK;
c Tameside General Hospital, UK
Aim: To examine, combined and individual predictive values regarding
Palpation (P), Mammogram (M), Ultrasound (U) and FNAC (C)/Core biopsy
(B) in Breast cancer diagnosis in relation to surgical biopsy.
Methods: 124 breast cancer patients reviewed between 1st April’09e30th
March'10. For diagnostic potential of combination of the modalities (P, M
and FNAC), we considered cases with score of 4 (Probablymalignant) and 5
(malignant) in any of the modalities were considered positive for malig-
nancy. All Patients diagnosed with breast cancer with triple assessment
were found having breast cancer on surgical biopsy. 12 were excluded,
unﬁt for intervention.
Results: (P) alone relatively accurate, conﬁrmed by surgical biopsy. PPV
58.9% when compared with surgical biopsy, PPV 66.1% after ultrasound
scan, the over Radiological grading (R) gives a PPV 81.3%, reﬂecting
important role of ultrasound. FNAC 73.2%, comparable with other studies.
Core biopsy diagnostic in 107 (95.5%). combination of the modalities (P, M,
U, R, FNAC) is more accurate than any one modality, alone.
Conclusion: Cases with positive three modalities for breast malignancy;
surgical biopsy conﬁrms the breast cancer with a PPV 100%, sensitivity
95.5%. Results showed improvement when compared to previous audit.
Furthermore, practice was in line with NICE guidelines and performance
was well above standard required.
0798: PRIMA: Y INVASIVE BREAST TUMOUR SIZE WITH AXILLARY
METASTASIS IN ETHNICITIES
X.Y. Kowa, M.F. Anwar*, F. Mihaimeed. Newham University Hospital, UK
Aim: To explore the correlation between breast cancer tumour size and
axillary lymph node metastasis in new presentations, amongst an ethni-
cally diverse patient population in an east London hospital.
Methods: A total of 131 patients were identiﬁed as ﬁrst presentations of
breast cancer over a two-year period based on the Trust's electronic
database (excluding recurrent breast disease or histological anomalies).
Tumour size was based on TNM staging and status of the axilla derived
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sentinel lymph node biopsy or axillary clearance.
Results: Analysis of the remaining 96 patients revealed strong negative
correlation (r ¼ 0.908) between increasing tumour size (T1 to T3) and
rate of axillary metastasis. 40% of all tumour T4 staged patients had
axillary involvement. Regardless of tumour size, South Asians had highest
tendency for axillary disease (42%) then followed by Afro-Caribbeans
(39%).
Conclusion: Based on our study, increasing primary tumour size is ironi-
cally associated with reduced rates of axillary disease. Chest wall and
cutaneous invasion strongly predict axillary metastasis. Ethnicity does
appear to alter the risk of lymphatic spread. However, further work with a
larger study population are needed for ﬁrm conclusions to be drawn.
0827: USE OF ONCOTYPE DX ASSAY REDUCES CHEMOTHERAPY IN
BREAST CANCER
T. Kiernan*, U. Sridharan, G. Mitchell. Royal Liverpool University Hospital,
UK
Aim: The future of breast cancer adjuvant treatment lies in molecular
proﬁling of tumours to determine their prognosis and sensitivity to
chemotherapy. Oncotype Dx is a 21 gene assay recommended for use by
NICE to guide adjuvant chemotherapy decisions for people with Oestrogen
Receptor positive (ER+), Lymph Node negative (LN-), Human Epidermal
growth factor Receptor 2 negative (HER2-) early breast cancer at inter-
mediate risk. Our aim is to audit the use of Oncotype Dx assay in the Royal
Liverpool University Hospital and to compare the assay score with tradi-
tional prognostic tools such as Nottingham Prognostic Index (NPI), Adju-
vant! Online and Predict.
Methods: Patients records, identiﬁed through Genomic database,
were searched for histology, demographics and adjuvant treatment
decision.
Results: 38 patients were identiﬁed, median age 59 (43e75); 16 were LN+.
76% did NOT receive chemotherapy following the assay; this represents a
40% reduction in expected use. There was no correlation of Oncotype Dx
score with the traditional prognostic tools.
Conclusion: Oncotype Dx assay should be used in all patients, including
LN+, considered for chemotherapy. Tumour histology does not necessarily
reﬂect molecular proﬁle, chemosensitivity and patient outcomes.0847: THE MANAGEMENT OF BREAST CANCER IN PATIENTS WITH
BREAST AUGMENTATION
L. Ballance a,*, D. Doherty b, A. Hamad a. aMid Cheshire Hospitals NHS
Foundation Trust, UK; bUniversity of Manchester, UK
Aim: Achieving balance between oncological and cosmetic outcomes in
Breast Cancer patients with breast augmentation (BA) is challenging. With
increasing age of womenwith BA, the management of Breast Cancer in this
cohort is likely to come under increased focus. Breast conserving surgery
(BCS) is less likely as it requires radiotherapy, with poor aesthetic out-
comes. There is a lack of clear guidance for this cohort with a call for
recommendations.
Methods: A literature review was carried out using PubMed and OVID
using key words and phrases: “breast cancer management”, “breast cancer
treatment”, “augmentation” and “previously augmented”. Papers pub-
lished since the year 2000 were considered.
Results: Fourteen papers were identiﬁed. BCS feasibility in Breast
Cancer patients with BA is low and mastectomy rates are high. BCS does
not compromise oncology outcomes but interferes with aesthetics.
Better cosmetic outcomes are seen with careful planning, patient se-
lection, novel reconstructive techniques and in those with sub-pectoral
implants.
Conclusion: There is no guidance for the management of Breast Cancer in
women with BA. BCS is a viable treatment option in these patients.
Treatment should be based on clinical judgement, patient preference and
preoperative counselling. Targeted radiation with novel reconstructive
methods may exclude aesthetic problems.0863: AXILLARY DISSECTION FOR BREAST CANCER MICROMETASTASES
TO THE SENTINEL NODE: OVERTREATMENT OR A NECESSARY EVIL?
M. Shastri*, W. Sotheran, T. Umar, L. Gould. St Richards Hospital, UK
Aim: The beneﬁts of sentinel lymph node (SN) biopsy for axillary staging
in breast cancer are well documented, although there is little consensus
regarding the subsequent management of micro and macro-metastatic
disease. We currently perform level I/II axillary dissection (AD) for SN
micrometastases in patients undergoing mastectomy, as not all receive
subsequent radiotherapy.
In this retrospective case series, we aim to determine whether there is any
beneﬁt in performing AD in mastectomy patients with micrometastases to
the SN.
Methods: We analysed histopathology reports of all patients who un-
derwent mastectomy and had micrometastases to one or more SN on One
Step Nucleic acid Ampliﬁcation (OSNA), during the 12 month period to
November 2014.
Results: 15 female patients were identiﬁed with a mean age of 59.1 years
(range 42e81 years). Most (n¼14) had invasive ductal or lobular carcinoma
+/ carcinoma in situ. Non SN involvement was present in 3 patients
however this did not result in upstaging of cancer in any case.
Conclusion: Within our cohort, AD for micrometastases to the SN in
mastectomy patients did not alter the pathological stage of cancer. We
therefore recommend AD is avoided as it does not alter patient manage-
ment and causes signiﬁcant morbidity.
0879: AUDIT OF THEATRE UTILISATION IN BREAST AND ENDOCRINE
SURGERY IN WISHAW GENERAL HOSPITAL
J. McAllister*, J. Murray. Wishaw General Hospital, UK
Aim: To determine the amount of time spent between cases and propor-
tion of theatre time spent operating in an elective breast and endocrine
practice.
Methods: The ORMIS theatre database was used to collect and analyse
timeswhenpatients entered and left theatre, andwhen surgery started and
ﬁnished. 33 operating lists performed by three surgeons were included,
comprising 146 cases over a 4-month period (January to May 2014).
Results: Of a potential 8-hour operating session (9-5), the average list
durationwas 6 hours 34minutes (including breaks). This meant an average
94% of potential available theatre time was utilised. Amongst this, 62% was
spent operating, 24%was spent prior to surgery starting, and 14%was spent
after surgery between cases. In total an average of 4 hrs 4 minutes were
spent operating (51% of potential theatre time spent operating). No signif-
icant difference was found between operating surgeon or anaesthetist.
Conclusion: Only half of the potential time available in theatre is spent
operating. While some of the other time is spent anaesthetising patients,
there is also a considerable amount of time spent with the transfer of
patients into and out of theatre.
0892: HAS THE USE OF IN-THEATRE INTRA-OPERATIVE SPECIMEN X-
RAY REDUCED OUR RE-OPERATION RATES IN BREAST CONSERVING
SURGERY?
E. Blower*, E. Redmond, J. Seward, C. Harding-Mackean. Countess of
Chester Hospital, UK
Aim: Negative margins at ﬁrst operation for breast conserving surgery
(BCS) reduce local recurrence, improve long-term breast conservation and
cosmesis. Gold-standard intra-operative conﬁrmation is departmental x-
ray. Recently, in-theatre assessment (Faxitron) may be alternatively used
allowing immediate assessment of tumour-margins. It may reduce re-
operation rates, anaesthesic time and cost. This audit aims to determine if
re-operation rates decreased and breast conservation rates increased
following Faxitron introduction.
Methods: A retrospective case-note review of consecutive patients un-
dergoing wide local excisions (WLE) both before and after Faxitron
introduction was performed. All image-guided specimens also underwent
standard departmental X-ray.
